These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6452236)

  • 1. Development of cell-mediated lympholysis in human foetal blood lymphocytes.
    Rayfield LS; Brent L; Rodeck CH
    Clin Exp Immunol; 1980 Dec; 42(3):561-70. PubMed ID: 6452236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human fetal lymphocytes require T cell growth factors for cytotoxic responses.
    Rayfield LS; Brent L; Boylston A; Rodeck CH; Modell B
    Clin Exp Immunol; 1987 Aug; 69(2):451-8. PubMed ID: 2958198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated lympholysis: examination of HLA genetic fine structure and complementation using cytotoxic lymphocytes.
    Schendel DJ; Wank R; Dupont B
    Eur J Immunol; 1978 Sep; 8(9):634-40. PubMed ID: 152205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional assay of HLA-directed non-T-cell mediated lympholysis (CML).
    Goeken NE; Thompson JS
    Transplant Proc; 1978 Dec; 10(4):943-6. PubMed ID: 153620
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated lympholysis by human maternal and neonatal lymphocytes: mother's reactivity against neonatal cells and vice versa.
    Granberg C; Hirvonen T; Toivanen P
    J Immunol; 1979 Dec; 123(6):2563-7. PubMed ID: 159319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor specific cell-mediated lympholysis (CML) by peripheral blood lymphocytes (PBL) from recipients with long-term renal grafts.
    Imai T; Takasaki E; Beck Y; Inoue S; Tseng CC; Sugimoto H; Nagao T; Akiyama N; Uchida H
    Transplant Proc; 1992 Aug; 24(4):1424-6. PubMed ID: 1386698
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxic T cell activity after HLA-mismatch bone marrow transplantation.
    Møller J; Dickmeiss E; Jacobsen N; Svejgaard A
    Tokai J Exp Clin Med; 1996 Feb; 21(1):19-23. PubMed ID: 9239800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of cell-mediated lympholysis in man.
    Geha RS; Malakian A; Geha O; Yunis E
    J Immunol; 1977 Apr; 118(4):1286-91. PubMed ID: 66285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
    Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
    Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation.
    Risdon G; Gaddy J; Stehman FB; Broxmeyer HE
    Cell Immunol; 1994 Mar; 154(1):14-24. PubMed ID: 8118883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated lympholysis in man: CML specificities and their possible relevance.
    Kristensen T
    Transplant Proc; 1978 Jun; 10(2):319-25. PubMed ID: 79254
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of human cytotoxic lymphocyte responses. I. Non-cytolytic suppression mediated by alloantigen-activated cells.
    Crosier PS; Broom BC
    Immunology; 1981 May; 43(1):11-8. PubMed ID: 6454646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses by cord blood cells.
    Roncarolo MG; Bigler M; Ciuti E; Martino S; Tovo PA
    Blood Cells; 1994; 20(2-3):573-85; discussion 585-6. PubMed ID: 7749123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
    Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
    Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans.
    Santoli D; Trinchieri G; Zmijewski CM; Koprowski H
    J Immunol; 1976 Sep; 117(3):765-70. PubMed ID: 956652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness.
    Kirk AD; Li RA; Kinch MS; Abernethy KA; Doyle C; Bollinger RR
    Transplantation; 1993 Apr; 55(4):924-31. PubMed ID: 8475569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro.
    Ware CF; Granger GA
    J Immunol; 1981 May; 126(5):1919-26. PubMed ID: 6452481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte-mediated cytotoxicity and humoral antibodies in human pregnancy.
    Chardonnens X; Jeannet M
    Int Arch Allergy Appl Immunol; 1980; 61(4):467-71. PubMed ID: 6444927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.